19-Dec-2025
Super Group is the best performing casino stock year-to-date
Seeking Alpha News (Fri, 19-Dec 12:05 PM ET)
Genius Sports' New Platform with FanDuel Brings Real-Time Game Insights to Over 300 NBA Broadcasts
Market Chameleon (Wed, 3-Dec 6:15 AM ET)
Market Chameleon (Wed, 3-Dec 4:03 AM ET)
Business Wire (Wed, 3-Dec 8:00 AM ET)
Business Wire (Tue, 2-Dec 8:00 AM ET)
CBF to Revolutionize Officiating With Genius Sports' Semi-Automated Offside Technology in 2026
Business Wire (Wed, 26-Nov 8:00 AM ET)
Genius Sports Partners with Publicis Sports to Reimagine Future of Fan Engagement
Business Wire (Tue, 25-Nov 7:00 AM ET)
ACCESS Newswire (Wed, 12-Nov 7:17 AM ET)
GENI Raises 2025 Guidance After Media Revenue Nearly Doubles and Group EBITDA Climbs 32%
Market Chameleon (Tue, 4-Nov 2:51 AM ET)
Business Wire (Tue, 4-Nov 7:00 AM ET)
Genius Sports Ltd is a B2B provider of scalable, technology-led products and services to the sports, sports betting, and sports media industries. Its services are organized into three key product areas including Sports Technology and Services; Betting Technology, Content and Services; and Media Technology, Content and Services. All of its products are powered by proprietary technology and robust data infrastructure. It generates maximum revenue from the Betting Technology, Content and Services division. Geographically, the company derives a majority of its revenue from Europe.
Genius Sports trades on the NYSE stock market under the symbol GENI.
As of December 19, 2025, GENI stock price climbed to $10.80 with 3,111,280 million shares trading.
GENI has a beta of 0.92, meaning it tends to be less sensitive to market movements. GENI has a correlation of 0.13 to the broad based SPY ETF.
GENI has a market cap of $2.51 billion. This is considered a Mid Cap stock.
Last quarter Genius Sports reported $166 million in Revenue and -$.11 earnings per share. This beat revenue expectation by $9 million and missed earnings estimates by -$.18.
In the last 3 years, GENI traded as high as $13.73 and as low as $3.12.
The top ETF exchange traded funds that GENI belongs to (by Net Assets): IWM, ARKW, IWO, WCMI, VTWO.
GENI has outperformed the market in the last year with a price return of +23.9% while the SPY ETF gained +18.1%. However, in the short term, GENI had mixed performance relative to the market. It has underperformed in the last 3 months, returning -15.6% vs +2.8% return in SPY. But in the last 2 weeks, GENI shares have fared better than the market returning -0.3% compared to SPY -0.5%.
GENI support price is $10.42 and resistance is $11.14 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GENI shares will trade within this expected range on the day.